I BRADYKININ & ANTI-BRADYKININ ANTISERUM— 510(k) K790362

Substantially Equivalent

Cambridge Nuclear Corp.

FDA 510(k) clearance K790362 for I BRADYKININ & ANTI-BRADYKININ ANTISERUM, Substantially Equivalent on 1979-04-23. Applicant: Cambridge Nuclear Corp..

Clearance details

Applicant: Cambridge Nuclear Corp.
Advisory panel: Unknown
Date received: 1979-02-22
Decision date: 1979-04-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.